BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11801732)

  • 1. The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells.
    Gasparian AV; Yao YJ; Kowalczyk D; Lyakh LA; Karseladze A; Slaga TJ; Budunova IV
    J Cell Sci; 2002 Jan; 115(Pt 1):141-51. PubMed ID: 11801732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells.
    Xu C; Shen G; Chen C; Gélinas C; Kong AN
    Oncogene; 2005 Jun; 24(28):4486-95. PubMed ID: 15856023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen.
    Palayoor ST; Youmell MY; Calderwood SK; Coleman CN; Price BD
    Oncogene; 1999 Dec; 18(51):7389-94. PubMed ID: 10602496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
    Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
    Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.
    Liptay S; Weber CK; Ludwig L; Wagner M; Adler G; Schmid RM
    Int J Cancer; 2003 Jul; 105(6):735-46. PubMed ID: 12767057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
    Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
    Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells.
    Suh J; Payvandi F; Edelstein LC; Amenta PS; Zong WX; Gélinas C; Rabson AB
    Prostate; 2002 Aug; 52(3):183-200. PubMed ID: 12111695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells.
    Gasparian AV; Yao YJ; Lü J; Yemelyanov AY; Lyakh LA; Slaga TJ; Budunova IV
    Mol Cancer Ther; 2002 Oct; 1(12):1079-87. PubMed ID: 12481431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol hexaphosphate inhibits constitutive activation of NF- kappa B in androgen-independent human prostate carcinoma DU145 cells.
    Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
    Anticancer Res; 2003; 23(5A):3855-61. PubMed ID: 14666688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.
    Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
    Oncogene; 2002 Mar; 21(11):1759-67. PubMed ID: 11896607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-tomatine attenuation of in vivo growth of subcutaneous and orthotopic xenograft tumors of human prostate carcinoma PC-3 cells is accompanied by inactivation of nuclear factor-kappa B signaling.
    Lee ST; Wong PF; He H; Hooper JD; Mustafa MR
    PLoS One; 2013; 8(2):e57708. PubMed ID: 23437404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells.
    Yang J; Richmond A
    Cancer Res; 2001 Jun; 61(12):4901-9. PubMed ID: 11406569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription.
    Devalaraja MN; Wang DZ; Ballard DW; Richmond A
    Cancer Res; 1999 Mar; 59(6):1372-7. PubMed ID: 10096573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice.
    Shanmugam MK; Rajendran P; Li F; Nema T; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Ho PC; Hui KM; Sethi G
    J Mol Med (Berl); 2011 Jul; 89(7):713-27. PubMed ID: 21465181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.
    Krappmann D; Emmerich F; Kordes U; Scharschmidt E; Dörken B; Scheidereit C
    Oncogene; 1999 Jan; 18(4):943-53. PubMed ID: 10023670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha.
    Clifton DR; Rydkina E; Freeman RS; Sahni SK
    Infect Immun; 2005 Jan; 73(1):155-65. PubMed ID: 15618150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.
    Arsura M; Panta GR; Bilyeu JD; Cavin LG; Sovak MA; Oliver AA; Factor V; Heuchel R; Mercurio F; Thorgeirsson SS; Sonenshein GE
    Oncogene; 2003 Jan; 22(3):412-25. PubMed ID: 12545162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.